CTSOVSDNA• 12 Months (Normalized)
CTSO vs DNA (Cytosorbents Corporation vs Ginkgo Bioworks Holdings Inc.)
Showing Closing Date Range from Sep 29, 2025 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $4.91
+%
Cytosorbents Corporation
Normalized Baseline0.00%
DNA Performance $10.46
-20.94%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
+20.94 pts
CTSO outperforming by 20.94 percentage points
CTSODNA
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO DNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | CTSO Price | CTSO Gain (%) | DNA Price | DNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 28, 2026 | $- | $10.46 | -20.94% | - | |
| Sep 25, 2026 | $- | $10.66 | -19.43% | - | |
| Sep 24, 2026 | $- | $10.25 | -22.52% | - | |
| Sep 23, 2026 | $4.91 | +430.81% | $8.58 | -35.15% | +465.96% |
| Sep 22, 2026 | $- | $9.37 | -29.18% | - | |
| Sep 21, 2026 | $5.51 | +495.68% | $7.98 | -39.68% | +535.36% |
| Sep 18, 2026 | $5.75 | +521.62% | $7.88 | -40.44% | +562.06% |
| Sep 17, 2026 | $5.76 | +522.70% | $7.84 | -40.74% | +563.44% |
| Sep 16, 2026 | $5.73 | +519.46% | $7.06 | -46.64% | +566.10% |
| Sep 15, 2026 | $6.06 | +555.14% | $6.99 | -47.17% | +602.31% |
| Sep 14, 2026 | $6.07 | +556.22% | $7.01 | -47.01% | +603.23% |
| Sep 11, 2026 | $6.41 | +592.97% | $6.75 | -48.98% | +641.95% |
| Sep 10, 2026 | $6.37 | +588.65% | $6.78 | -48.75% | +637.40% |
| Sep 09, 2026 | $6.33 | +584.32% | $6.79 | -48.68% | +633.00% |
| Sep 08, 2026 | $- | $6.94 | -47.54% | - |
Page 1 of 17